SL
SRY Labs
Retatrutide
146 tests · latest 16 Jun 2026
61%
NEA rating
#11 of 26 Retatrutide vendors
2 of 4 classifiable tests passed
natural 88% · customers 4.2★ (10)
NEA analysis · Retatrutide
SRY Labs Retatrutide is a mixed picture: purity reads 96.5% while fill comes in light at 89.6% of label. Expect batch to batch swings and confirm the lot before relying on the number.
Purity focus — purity 99.5%+, dose ±35%methodology
Peptides
8 rated · tap to focus| # | Peptide | Rating | N |
|---|---|---|---|
| 1 | Retatrutideselected | 61% | 4 |
| 2 | CJC 1295 | 60% | 27 |
| 3 | Semax | 58% | 4 |
| 4 | Semaglutide | 54% | 33 |
| 5 | GHK Cu | 52% | 20 |
| 6 | GLOW | 50% | 23 |
| 7 | Tirzepatide | 49% | 20 |
| 8 | BPC 157 | 31% | 15 |
Rating trend
Retatrutide rating from this vendor, after each test
SRY Labs Retatrutide test history
4 tests · 2 pass · 2 fail
| Date | Result | Purity | Dosage | Label |
|---|---|---|---|---|
| 16 Jun 2026 | Fail | 96.1%Content Fail | -13.6%17.28 mg tested / 20 mg label | Batch RE202604sent by Vendor |
| 22 May 2026 | Pass | 96.1%Identity Pass | -6.9%18.62 mg tested / 20 mg label | Batch RE202603sent by Vendor |
| 29 Apr 2026 | Pass | 97.17%Identity Pass | -3.6%19.28 mg tested / 20 mg label | Batch RE202602sent by Vendor |
| 22 Apr 2026 | Fail | 96.6%Content Fail | -17.5%16.5 mg tested / 20 mg label | Batch RE202601sent by Vendor |
1-4 of 4